Nocardia sp. strain CS682 is a rare actinobacterium with a promising ability to produce secondary metabolites such as nargenicin A1 (an effective antibacterial compound) and IBR-3 (a UV-protectant molecule). Here, we report the complete genome sequence of Nocardia sp. CS682, obtained by PacBio sequencing as a single contig with 8,919,230 bp (GC content, 63.3%).
N ocardia spp. are rare actinobacteria that are generally characterized as a source of diverse biomolecules with antibacterial, antifungal, cytotoxic, and immunosuppressive activities (1, 2) . The major secondary metabolite derived from Nocardia sp. strain CS682 is nargenicin A1, an antibacterial polyketide with promising activity against various Gram-positive pathogenic bacteria (3) . Similarly, IBR-3, a novel tetrahydroxynaphthalene (THN) derivative with UV protection effects, was also isolated from strain CS682 (4).
Strain CS682 was isolated from soil samples from Jeonnam, Republic of Korea, while screening for bacterial strains producing potential antibiotics against methicillinresistant Staphylococcus aureus (MRSA) (3) . For genomic extraction, strain CS682 was cultured in brain heart infusion (BHI) medium at 37°C and 200 rpm for 5 days (5) . The genomic DNA of Nocardia sp. CS682 was isolated and purified using the TIANamp bacterial DNA kit. A PacBio SMRTbell library was constructed and sequenced on the PacBio RS platform (Macrogen, Inc., Republic of Korea) (6, 7) . The Hierarchical Genome Assembly Process (HGAP) algorithm was executed in the Web-based graphical user interface (GUI) in the SMRT Analysis pipeline version 2.3.0 for preparing the PacBio library and for high-quality de novo assembly of the genome from PacBio raw reads. There were 152,943 sequence reads with a mean subread length of 9,897 bp, resulting in 189-fold sequencing coverage of the genome. Furthermore, a consensus sequence of higher quality was generated by validating the mapping reads against assembled contigs and error correcting using Quiver version 2.1.0 (8) . Finally, the CS682 genome was assembled into a single contig. The genome was annotated with the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) version 4.5 (9) . The autoMLST pipeline (https:// automlst.ziemertlab.com/download) (10) was used for determining closely related genomes based on alignment of core genes, and the closest species were determined based on percent average nucleotide identity (ANI). For determining the biosynthetic gene clusters (BGCs) in the genome, antiSMASH bacterial version 4.0 (11) was used. Default parameters were used for all software unless otherwise specified.
The assembled genome of strain CS682 was obtained as a single contig with 8,919,230 bp (GC content, 63.3%). A total of 7,856 open reading frames (ORFs), 56 tRNAs, 3 rRNA genes (5S, 16S, and 23S rRNA), and 3 noncoding RNA (ncRNA) genes were identified ( Table 1 ). The estimated ANI values of Nocardia sp. CS682 with different Nocardia spp. were 86.7% (Nocardia altamirensis NBRC 108246; RefSeq assembly accession no. GCF_001612685), 86.7% (Nocardia brasiliensis ATCC 700358; GCF_000250675), and 86.7% (Nocardia brasiliensis NBRC 14402; GCF_000308475). These observations establish that Nocardia sp. CS682 has higher similarities to Nocardia altamirensis and Nocardia brasiliensis than to other species. The antiSMASH 4.0 results revealed that strain CS682 contains 44 putative BGCs, including clusters for polyketides, nonribosomal peptides, ectoine, terpenes, etc. The genomic architecture of strain CS682 also provided insight on precise locations of BGCs of nargenicin A1 (2) and IBR-3 (3) within the genome.
Data availability. The genome sequence of Nocardia sp. strain CS682 can be accessed in the NCBI database under accession no. CP029710. The PacBio raw reads have been submitted to the Sequence Read Archive (SRA) under accession no. SRX6973800, SRX6973801, and SRX6973802.
ACKNOWLEDGMENT
This work was supported by National Research Foundation of Korea (NRF) grants funded by the South Korean government (MEST) (grants NRF-2017R1A2A2A05000939 to J.K.S. and NRF-2017R1D1A1B03036273 to D.D.). 
